North America Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Large Molecule Injectables and Small Molecule Injectables), Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others), Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others)

Code: BMIRE00025004 | Pages: 161 | Industry: Pharmaceuticals | Date: Jun 2022 | Type: Regional

The generic injectables market in North America is expected to grow from US$ 22,072.74 million in 2021 to US$ 45,208.73 million by 2028; it is estimated to grow at a CAGR of 10.8% from 2021 to 2028.

Generic injectables are as safe and effective as innovator molecules because they are bioequivalent to their branded counterparts, but they are not patented for many reasons. These medications can be produced for commercial usage only after the patent expiration of the branded drug. As the drug molecules are similar in branded and generic formulation, no or minimal R&D cost is associated with generic injectables. The low upfront R&D costs allow drug manufacturers to sell generic injectables at lower prices. As stated by the United States Food and Drug Administration (US FDA), a single generic competitor can lead to price reductions of 30%, while five generics competing could lead to price drops of ~85%. Additionally, generic injectables saved US$ 2.2 trillion for the US healthcare system during 2009–2019. As mentioned in a report by Congressional Budget Office, the pharmaceutical industry spent US$ 83 billion on R&D in 2019. However, with generic injectables, the repetition of clinical studies is not required to demonstrate their effectiveness and safety, which contributes to their low prices. Further, the approval process for generic medicines is faster than for branded ones. As reported by the United States Food and Drug Administration (USFDA), in 2019, 107 first generic drugs and 110 complex generic drugs were approved, totaling 11% of the generic drug product approvals. Overall, in 2019, the generic drug program approved or tentatively approved 1,014 generic drug applications. Additionally, the development of a new chemical entity takes almost a decade on average, which is bypassed in the development of generic injectables. Thus, the low cost associated with generic injectables is one of the major factors attracting new players to enter the market and driving the generic injectables market.

North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :


North America Generic Injectables Market Segmentation 

The North America generic injectables market is segmented into product type, container type, application, route of administration, and country. Based on product type, the market has been segmented into large molecule injectable and small molecule injectable. In 2020, the large molecule injectable segment held a larger market share. In terms of container type, the market has been categorized into vials, premix, prefilled syringes, ampoules, and others. In 2020, the vials segment held the largest share of the market. Based on application, the market has been segmented into oncology, infectious diseases, cardiology, diabetes, immunology, and others. In 2020, the oncology segment held the largest share of the market. Based on route of administration, the market has been categorized into intravenous, intramuscular, subcutaneous, and others. In 2020, the intravenous segment held the largest market share. Based on country, the North America generic injectables market is segmented into the US, Canada, and Mexico. The US contributed a substantial share in 2020. 

AstraZeneca; Baxter International Inc.; Biocon; Fresenius SE & Co. KGaA; GlaxoSmithKline plc; Hikma Pharmaceuticals PLC; Johnson and Johnson Services, Inc.; Lupin; Merck & Co., Inc.; Pfizer Inc.; and Viatris Inc are among the leading companies in the North America generic injectables market.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Generic injectables Market – By Product Type

1.3.2        North America Generic injectables Market – By Container Type

1.3.3        North America Generic injectables Market – By Application

1.3.4        North America Generic injectables Market – By Route of Administration

1.3.5        North America Generic injectables Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Generic Injectables Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           North America Generic Injectables Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Low R&D, Marketing, and Manufacturing Costs

5.1.2        High Demand for Affordable Drugs

5.2         Market Restraints

5.2.1        Critical Inspection System for Prefilled Injection

5.3         Market Opportunities

5.3.1        Increasing Patent Expiry of Drugs

5.4         Future Trends

5.4.1        Government Support for Generic Injectables Production and Healthcare Cost Reduction

5.5         Impact Analysis

6.           Generic Injectables Market– North America Analysis

6.1         North America Generic Injectables Market Revenue Forecast and Analysis

7.           North America Generic Injectables Market– by Product Type

7.1         Overview

7.2         North America Generic Injectables Market, By Product Type, 2021 & 2028 (%)

7.3         Large Molecule Injectables

7.3.1        Overview

7.3.2        Large Molecule Injectables: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

7.4         Small Molecule Injectables

7.4.1        Overview

7.4.2        Small Molecule Injectables: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.           North America Generic Injectables Market– by Container Type

8.1         Overview

8.2         North America Generic Injectables Market, By Container Type, 2021 & 2028 (%)

8.3         Vials

8.3.1        Overview

8.3.2        Vials: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.4         Premix

8.4.1        Overview

8.4.2        Premix: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.5         Prefilled Syringes

8.5.1        Overview

8.5.2        Prefilled Syringes: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.6         Ampoules

8.6.1        Overview

8.6.2        Ampoules: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Generic Injectables Market– by Application

9.1         Overview

9.2         North America Generic Injectables Market, By Application, 2021 & 2028 (%)

9.3         Oncology

9.3.1        Overview

9.3.2        Oncology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.4         Infectious Diseases

9.4.1        Overview

9.4.2        Infectious Diseases: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.5         Cardiology

9.5.1        Overview

9.5.2        Cardiology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.6         Diabetes

9.6.1        Overview

9.6.2        Diabetes: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.7         Immunology

9.7.1        Overview

9.7.2        Immunology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.8         Others

9.8.1        Overview

9.8.2        Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Generic Injectables Market– by Route of Administration

10.1      Overview

10.2      North America Generic Injectables Market, By Route of Administration, 2021 & 2028 (%)

10.3      Intravenous

10.3.1     Overview

10.3.2     Intravenous: North America North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.4      Intramuscular

10.4.1     Overview

10.4.2     Intramuscular: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.5      Subcutaneous

10.5.1     Overview

10.5.2     Subcutaneous: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

11.        North America Generic Injectables Market– Country Analysis

11.1      North America: Generic Injectables Market Revenue and Forecast to 2028

11.1.1     Overview

11.1.2     North America: Generic Injectables Market, by Country, 2020 & 2028 (%)

11.1.2.1       US: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1       US: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.2       US: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.2.1.3       US: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.2.1.4       US: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.2.1.5       US: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.2       Canada: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1       Canada: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.2       Canada: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.2.2.3       Canada: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.2.2.4       Canada: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.2.2.5       Canada: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.3       Mexico: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1       Mexico: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.2       Mexico: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.2.3.3       Mexico: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.2.3.4       Mexico: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.2.3.5       Mexico: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

12.        North America Generic Injectables Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      AstraZeneca

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Baxter International Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Biocon

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Fresenius SE & Co. KGaA

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      GlaxoSmithKline plc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Hikma Pharmaceuticals PLC

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Johnson and Johnson Services, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Lupin

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Viatris Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Merck & Co., Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

13.11   Pfizer Inc.

13.11.1  Key Facts

13.11.2  Business Description

13.11.3  Products and Services

13.11.4  Financial Overview

13.11.5  SWOT Analysis

13.11.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Generic injectables Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             US Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             US Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 5.             US Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 6.             Canada Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Canada Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 9.             Canada Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 10.          Mexico Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          Mexico Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          Mexico Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          Mexico Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          Organic Developments Done By Companies

Table 15.          Inorganic Developments Done By Companies

Table 16.          Glossary of Terms, North America Generic Injectables Market

 


LIST OF FIGURES

Figure 1.           North America Generic injectables Market Segmentation

Figure 2.           North America Generic injectables Market, By Country

Figure 3.           North America Generic Injectables Market Overview

Figure 4.           Large Molecule Injectable Segment Held Largest Share of Product Type Segment in North America Generic injectables Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           North America Generic injectables Market Impact Analysis of Driver and Restraints

Figure 9.           North America Generic Injectables Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        North America Generic Injectables Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Large Molecule Injectables: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Small Molecule Injectables: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Generic Injectables Market, by Container Type, 2021 & 2028 (%)

Figure 14.        Vials: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Premix: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Prefilled Syringes: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Ampoules: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        North America Generic Injectables Market, by Application, 2021 & 2028 (%)

Figure 20.        Oncology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Infectious Diseases: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Cardiology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diabetes: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Immunology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        North America Generic Injectables Market, by Route of Administration, 2021 & 2028 (%)

Figure 27.        Intravenous: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Intramuscular: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Subcutaneous: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        North America: Generic Injectables Market, by Key Country – Revenue (2021) (USD Million)

Figure 32.        North America: Generic Injectables Market, by Country, 2020 & 2028 (%)

Figure 33.        US: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        Canada: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Mexico: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

  1. AstraZeneca
  2. Baxter International Inc.
  3. Biocon
  4. Fresenius SE & Co. KGaA
  5. GlaxoSmithKline plc
  6. Hikma Pharmaceuticals PLC
  7. Johnson and Johnson Services, Inc.
  8. Lupin
  9. Merck & Co., Inc.
  10. Pfizer Inc.
  11. Viatris Inc
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000